AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE